Table 3 Histological changes between bicyclol group and ETV group after 48-week treatment
variables | Bicyclol group (n = 30) | ETV group (n = 30) |
|---|---|---|
Inflammation activity, n (%) | ||
Inflammation improvement | 16 (53.3) | 19 (63.3) |
No change | 12 (40.0) | 10 (33.4) |
Inflammation progression | 2 (6.7) | 1 (3.3) |
Liver Fibrosis, n (%) | ||
Fibrosis improvement | 11 (36.7) | 13 (43.4) |
No change | 16 (53.3) | 16 (53.3) |
Fibrosis progression | 3 (10.0) | 1 (3.3) |